NS

Najam A. Sharif

AM Alcon Manufacturing: 12 patents #1 of 72Top 2%
AR Alcon Research: 6 patents #31 of 267Top 15%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
AL Alcon: 2 patents #370 of 866Top 45%
AP Astellas Pharma: 1 patents #544 of 954Top 60%
SC Santen Pharmaceutical Co.: 1 patents #178 of 291Top 65%
Google: 1 patents #14,769 of 22,993Top 65%
📍 Arlington, TX: #38 of 1,708 inventorsTop 3%
🗺 Texas: #5,391 of 125,132 inventorsTop 5%
Overall (All Time): #172,043 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
11331311 Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compound Tomoko KIRIHARA, Atsushi Shimazaki 2022-05-17
10016441 Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension David Ellis, Lukas Scheibler 2018-07-10
9604949 Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension David Ellis, Lukas Scheibler 2017-03-28
8263555 Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma 2012-09-11
8252793 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma Keith Combrink, Suchismita Mohapatra, Mark R. Hellberg, Ganesh Prasanna, Iok-Hou Pang +3 more 2012-08-28
8173668 Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension and glaucoma 2012-05-08
7867999 Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions Hwang-Hsing Chen, Mark R. Hellberg 2011-01-11
7807629 Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma 2010-10-05
7718697 Method for treating glaucoma comprising administering α-lipoic acid Colene Drace, Gary Williams, Curtis R. Kelly 2010-05-18
7655662 (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure Mark R. Hellberg, Jesse A. May, Andrew Rusinko, Hwang-Hsing Chen 2010-02-02
7285553 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders Jesse A. May, Thomas R. Dean, Hwang-Hsing Chen 2007-10-23
7235556 Methods of treating dry eye disorders Mark R. Hellberg 2007-06-26
7060704 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders Jesse A. May, Thomas R. Dean, Hwang-Hsing Chen 2006-06-13
6960579 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders Jesse A. May, Thomas R. Dean, Hwang-Hsing Chen 2005-11-01
6664286 Serotonergic 5ht2 agonists for treating glaucoma Jesse A. May, Thomas R. Dean, Mark R. Hellberg 2003-12-16
6649655 11&bgr;-fluoro 15&bgr;-hydroxy PGF2&agr; analogs as FP receptor antagonists Brenda W. Griffin 2003-11-18
6545045 Prostaglandin E agonists for treatment of glaucoma Peter G. Klimko, Brenda W. Griffin 2003-04-08
6531480 Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders 2003-03-11
6500831 Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma 2002-12-31
6492417 11-deoxy-16-fluoro-PGF2&agr; analogs as FP receptor antagonists Brenda W. Griffin 2002-12-10
6441033 11&bgr;-fluoro 15&bgr;-hydroxy PGF2&agr; analogs as FP receptor antagonists Brenda W. Griffin 2002-08-27
6344477 Prostaglandin e agonists for treatment of dry eye 2002-02-05
6291479 Use of NR2B-selective NMDA-receptor antagonists for the treatment of ophthalmic diseases 2001-09-18
6284537 Immortalized human corneal epithelial cell line Elizabeth Offord Cavin, Andrea Pfeifer, Yvonne Tromvoukis 2001-09-04